This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kitazawa, M. Articles by LaFerla, F. M. Search for Related Content PubMed PubMed Citation Articles by Kitazawa, M. Articles by LaFerla, F. M.

(American Journal of Pathology. 2006;168:1986-1997.)
© 2006 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2006.051232

Genetically Augmenting Aß42 Levels in Skeletal Muscle Exacerbates Inclusion Body Myositis-Like Pathology and Motor Deficits in Transgenic Mice

From the Department of Neurobiology and Behavior, Laboratory of Molecular Neuropathogenesis, University of California, Irvine, Irvine, California

The pathogenic basis of inclusion body myositis (IBM), the leading muscle degenerative disease afflicting the elderly, is unknown, although the histopathological features are remarkably similar to those observed in Alzheimer’s disease. One leading hypothesis is that the buildup of amyloid-ß (Aß) peptide within selective skeletal muscle fibers contributes to the degenerative phenotype. Aß is a small peptide derived via endoproteolysis of the amyloid precursor protein (APP). To determine the pathogenic effect of augmenting Aß42 levels in skeletal muscle, we used a genetic approach to replace the endogenous wild-type presenilin-1 (PS1) allele with the PS1_M146V allele in MCK-APP mice. Although APP transgene expression was unaltered, Aß levels, particularly Aß42, were elevated in skeletal muscle of the double transgenic (MCK-APP/PS1) mice compared to the parental MCK-APP line. Elevated phospho-tau accumulation was found in the MCK-APP/PS1 mice, and the greater activation of GSK-3ß and cdk5 were observed. Other IBM-like pathological features, such as inclusion bodies and inflammatory infiltrates, were more severe and prominent in the MCK-APP/PS1 mice. Motor coordination and balance were more adversely affected and manifested at an earlier age in the MCK-APP/PS1 mice. The data presented here provide experimental evidence that Aß42 plays a proximal and critical role in the muscle degenerative process.

This article has been cited by other articles:

				I E Muth, K Barthel, M Bahr, M C Dalakas, and J Schmidt Proinflammatory cell stress in sporadic inclusion body myositis muscle: overexpression of {alpha}B-crystallin is associated with amyloid precursor protein and accumulation of {beta}-amyloid J. Neurol. Neurosurg. Psychiatry, December 1, 2009; 80(12): 1344 - 1349. [Abstract] [Full Text] [PDF]

				S. A Greenberg How citation distortions create unfounded authority: analysis of a citation network BMJ, July 23, 2009; 339(jul20_3): b2680 - b2680. [Abstract] [Full Text] [PDF]

				M. Kitazawa, V. Vasilevko, D. H. Cribbs, and F. M. LaFerla Immunization with Amyloid-{beta} Attenuates Inclusion Body Myositis-Like Myopathology and Motor Impairment in a Transgenic Mouse Model J. Neurosci., May 13, 2009; 29(19): 6132 - 6141. [Abstract] [Full Text] [PDF]

				J. Schmidt and M. C. Dalakas Inflammation interrelates to APP in sIBM: IL-1{beta} induces accumulation of {beta}-amyloid Brain, April 1, 2009; 132(4): e107 - e107. [Full Text] [PDF]

				J. Schmidt, K. Barthel, A. Wrede, M. Salajegheh, M. Bahr, and M. C. Dalakas Interrelation of inflammation and APP in sIBM: IL-1{beta} induces accumulation of {beta}-amyloid in skeletal muscle Brain, May 1, 2008; 131(5): 1228 - 1240. [Abstract] [Full Text] [PDF]

				V. Fonte, D. R. Kipp, J. Yerg III, D. Merin, M. Forrestal, E. Wagner, C. M. Roberts, and C. D. Link Suppression of in Vivo -Amyloid Peptide Toxicity by Overexpression of the HSP-16.2 Small Chaperone Protein J. Biol. Chem., January 11, 2008; 283(2): 784 - 791. [Abstract] [Full Text] [PDF]